Author’s contribution:
APR: conception and design of the study, acquisition of data, analysis and interpretation of data, drafting the article
MF: acquisition of data, analysis and interpretation of data
KN: analysis and interpretation of data, statistics, revising the article
BM: acquisition of data, revising the article critically for important intellectual content
BS: acquisition of data
LR: analysis and interpretation of data, revising the article critically for important intellectual content
DS: conception and design of the study, revising the article critically for important intellectual content
Details of Ethics Approval - Institutional review board approval was obtained from the Ethical Committee of the Canton Berne (reference number 2020-00832).
Funding: No funding has been received for conducting the study
References
  1. Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M. COVID-19 and diabetes: A bidirectional relationship. COVID-19 y diabetes mellitus: una relación bidireccional. Clin Investig Arterioscler . 2021;33(3):151-157. doi:10.1016/j.arteri.2020.10.001
  2. Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan. China: A single-centered, retrospective, observational study. Lancet Respir Med.  2020;8:475–481.
  3. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med.  2020;382:1708–1720.
  4. De Almeida-Pititto B., Dualib P.M., Zajdenverg L., Rodrigues Dantas J., Dias de Souza F., Rodacki M. Severity and mortality of COVID-19 in patients with diabetes, hypertension and cardiovascular disease: A meta-analysis. Diabetol Metab Syndr.  2020;12:75.
  5. Vouga, M., Favre, G., Martinez-Perez, O. et al.  Maternal outcomes and risk factors for COVID-19 severity among pregnant women. Sci Rep  11,  13898 (2021). https://doi.org/10.1038/s41598-021-92357-y
  6. Gurol-Urganci I, Jardine JE, Carroll F, et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol 2021
  7. Hill MA, Mantzoros C, Sowers JR. Commentary: COVID-19 in patients with diabetes. Metabolism . 2020;107:154217. doi:10.1016/j.metabol.2020.154217
  8. Philips BJ, Meguer JX, Redman J, Baker EH. Factors determining the appearance of glucose in upper and lower respiratory tract secretions.Intensive Care Med . 2003;29(12):2204-2210. doi:10.1007/s00134-003-1961-2
  9. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358(19):1991-2002.
  10. Eberle, C., James-Todd, T. & Stichling, S. SARS-CoV-2 in diabetic pregnancies: a systematic scoping review. BMC Pregnancy Childbirth  21,  573 (2021). https://doi.org/10.1186/s12884-021-03975-3
  11. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care . 2010;33(3):676-682. doi:10.2337/dc09-1848
  12. M Cauldwell, Y van-de-L’Isle, I Watt Coote, PJ Steer. Seasonal and SARS-CoV-2 pandemic changes in the incidence of gestational diabetes. BJOG 2021. https://doi.org/10.1111/1471-0528.16779
  13. C-T Wu, PV. Lidsky, Y Xiao et al. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Cell Metabolism. Volume 33, Issue 8, 2021, https://doi.org/10.1016/j.cmet.2021.05.013.
  14. B Eskenazi, S Rauch, E Iurlaro et al, Diabetes mellitus,maternal adiposity, and insulin-dependent gestational diabetes are associated with Covid-19 in pregnancy: The INTERCOVID Study, American Journal of Obstetrics and Gynecology (2022), doi: https://doi.org/10.1016/j.ajog.2021.12.032.
  15. Panchaud A, Favre G, Pomar L, Vouga M, Aebi-Popp K, Baud D; COVI-Preg group. An international registry for emergent pathogens and pregnancy. Lancet. 2020 May 9;395(10235):1483-1484. doi: 10.1016/S0140-6736(20)30981-8. Epub 2020 Apr 27. PMID: 32353329; PMCID: PMC7185939.
  16. Aubry EM, Raio L, Oelhafen S. Effect of the IADPSG screening strategy for gestational diabetes on perinatal outcomes in Switzerland. Diabetes Res Clin Pract. 2021 May;175:108830. doi: 10.1016/j.diabres.2021.108830. Epub 2021 Apr 22. PMID: 33895193.
  17. Clinical Spectrum | COVID-19 Treatment Guidelines (nih.gov)
  18. Amaral WND, Moraes CL, Rodrigues APDS, Noll M, Arruda JT, Mendonça CR. Maternal Coronavirus Infections and Neonates Born to Mothers with SARS-CoV-2: A Systematic Review. Healthcare (Basel). 2020 Nov 24;8(4):511. doi: 10.3390/healthcare8040511. PMID: 33255184; PMCID: PMC7712854.
  19. Allotey J, Stallings E, Bonet M et al; for PregCOV-19 Living Systematic Review Consortium. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020 Sep 1;370:m3320. doi: 10.1136/bmj.m3320. PMID: 32873575; PMCID: PMC7459193.
  20. Radan AP, Aleksandra Polowy J, Heverhagen A et al. Cervico-vaginal placental α-macroglobulin-1 combined with cervical length for the prediction of preterm birth in women with threatened preterm labor. Acta Obstet Gynecol Scand. 2020 Mar;99(3):357-363. doi: 10.1111/aogs.13744. Epub 2019 Oct 28. PMID: 31587255.
  21. Patel JA, Nielsen FBH, Badiani AA, et al. Poverty, inequality and COVID-19: the forgotten vulnerable. Public Health . 2020;183:110-111. doi:10.1016/j.puhe.2020.05.006
  22. CDC Statement on Pregnancy Health Advisory | CDC Online Newsroom | CDC
  23. Update on WHO Interim recommendations on COVID-19 vaccination of pregnant and lactating women
  24. Vaccines - Johns Hopkins Coronavirus Resource Center (jhu.edu)